Search Results - "Poignard, Pascal"

Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study.

Authors: Bal, Antonin Brengel-Pesce, Karen Gaymard, Alexandre et al.

Source: Scientific Reports. 7/22/2021, Vol. 11 Issue 1, p1-10. 10p.

Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding.

Authors: Scheid, Johannes F. Mouquet, Hugo Ueberheide, Beatrix et al.

Source: Science (pre-March 2025); 9/16/2011, Vol. 333 Issue 6049, p1633-1637, 5p

Publisher Correction: Clinical and laboratory characteristics of symptomatic healthcare workers with suspected COVID-19: a prospective cohort study.

Authors: Bal, Antonin Brengel-Pesce, Karen Gaymard, Alexandre et al.

Source: Scientific Reports. 9/23/2021, Vol. 11 Issue 1, p1-2. 2p.

SARS-CoV-2 Variants in Immunocompromised Patient Given Antibody Monotherapy.

Authors: Truffot, Aurélie Andréani, Julien Le Maréchal, Marion et al.

Source: Emerging Infectious Diseases. Oct2021, Vol. 27 Issue 10, p2725-2728. 4p.

Effective, low-titer antibody protection against low-dose repeated mucosal SHIV challenge in macaques.

Authors: Hessell, Ann J. Poignard, Pascal Hunter, Meredith et al.

Source: Nature Medicine. Aug2009, Vol. 15 Issue 8, p951-954. 4p. 2 Charts, 2 Graphs.

Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target.

Authors: Walker, Laura M. Phogat, Sanjay K. Po-Ying Chan-Hui et al.

Source: Science (pre-March 2025). 10/9/2009, Vol. 326 Issue 5950, p285-289. 5p.

Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers.

Authors: Hessell, Ann J. Rakasz, Eva G. Poignard, Pascal et al.

Source: PLoS Pathogens. May2009, Vol. 5 Issue 5, p1-9. 9p. 4 Charts, 3 Graphs.

AKR1B10, One of the Triggers of Cytokine Storm in SARS-CoV2 Severe Acute Respiratory Syndrome.

Authors: Chabert, Clovis Vitte, Anne-Laure Iuso, Domenico et al.

Source: International Journal of Molecular Sciences. Feb2022, Vol. 23 Issue 3, p1911-N.PAG. 1p.

Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies.

Authors: Krumm, Stefanie A. Mohammed, Hajer Le, Khoa M. et al.

Source: Retrovirology. 2/2/2016, Vol. 13, p1-15. 15p.

Incomplete Neutralization and Deviation from Sigmoidal Neutralization Curves for HIV Broadly Neutralizing Monoclonal Antibodies.

Authors: McCoy, Laura E. Falkowska, Emilia Doores, Katie J. et al.

Source: PLoS Pathogens. 8/12/2015, Vol. 11 Issue 8, p1-19. 19p.

Toward a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding.

Authors: Linling He Sok, Devin Azadnia, Parisa et al.

Source: Scientific Reports. 10/31/2014, p1-12. 12p.

IDEPI: Rapid Prediction of HIV-1 Antibody Epitopes and Other Phenotypic Features from Sequence Data Using a Flexible Machine Learning Platform.

Authors: Hepler, N. Lance Scheffler, Konrad Weaver, Steven et al.

Source: PLoS Computational Biology. Sep2014, Vol. 10 Issue 9, p1-10. 10p.

A Human Antibody to the CD4 Binding Site of gp120 Capable of Highly Potent but Sporadic Cross Clade Neutralization of Primary HIV-1.

Authors: Gach, Johannes S. Quendler, Heribert Tong, Tommy et al.

Source: PLoS ONE. Aug2013, Vol. 8 Issue 8, p1-14. 14p.

Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans

Authors: Julien, Jean-Philippe Sok, Devin Khayat, Reza et al.

Source: PLoS Pathogens. May2013, Vol. 9 Issue 5, p1-15. 15p. 4 Diagrams, 2 Charts, 1 Graph.

A gp41 MPER-specific Llama VHH Requires a Hydrophobic CDR3 for Neutralization but not for Antigen Recognition.

Authors: Hulsik, David Lutje Liu, Ying-ying Strokappe, Nika M. et al.

Source: PLoS Pathogens. Mar2013, Vol. 9 Issue 3, p1-16. 16p. 1 Color Photograph, 1 Diagram, 2 Charts, 5 Graphs.